Accelerate Diagnostics, Inc.
AXDX
$0.9248
-$0.0171-1.82%
| 12/31/2023 | 09/30/2023 | ||||
|---|---|---|---|---|---|
| Revenue | -8.24% | 12.94% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -8.24% | 12.94% | |||
| Cost of Revenue | -25.00% | 50.42% | |||
| Gross Profit | 491.59% | -86.61% | |||
| SG&A Expenses | -25.36% | 2.60% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -23.36% | 15.76% | |||
| Operating Income | 26.76% | -16.41% | |||
| Income Before Tax | -1,294.43% | 103.20% | |||
| Income Tax Expenses | 330.53% | -16.03% | |||
| Earnings from Continuing Operations | -1,528.35% | 102.78% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -1,528.35% | 102.78% | |||
| EBIT | 26.76% | -16.41% | |||
| EBITDA | 28.36% | -17.53% | |||
| EPS Basic | -1,515.40% | 102.12% | |||
| Normalized Basic EPS | 28.50% | 9.01% | |||
| EPS Diluted | -1,586.17% | 102.02% | |||
| Normalized Diluted EPS | 27.91% | 9.77% | |||
| Average Basic Shares Outstanding | 1.00% | 31.10% | |||
| Average Diluted Shares Outstanding | 0.16% | 32.19% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
